Recruiting Anxiety Studies in Torrance
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
A Phase 3, Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Generalized Anxiety Disorder - Panorama...
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
This U.S. Phase 3 clinical trial is designed to evaluate the efficacy, safety, and tolerability of the acute intranasal (i.n.) administration of Fasedienol Nasal Spray (fasedienol) (3.2 µg) to relieve...
About Anxiety Clinical Trials in Torrance
Anxiety disorders are the most common mental health conditions, involving persistent, excessive worry that interferes with daily activities. Types include generalized anxiety disorder, panic disorder, and social anxiety disorder. Treatment includes cognitive behavioral therapy and medications.
There are currently 2 anxiety clinical trials recruiting participants in Torrance, CALIFORNIA. These studies are seeking a combined 486 participants. Research is being sponsored by Mind Medicine, Inc., VistaGen Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Anxiety Clinical Trials in Torrance — FAQ
Are there anxiety clinical trials in Torrance?
Yes, there are 2 anxiety clinical trials currently recruiting in Torrance, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Torrance?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Torrance research site will contact you about next steps.
Are clinical trials in Torrance free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Torrance studies also compensate for your time and travel.
What anxiety treatments are being tested?
The 2 active trials in Torrance are testing new therapies including novel drugs, biologics, and treatment approaches for anxiety.
Data updated March 2, 2026 from ClinicalTrials.gov